BIIB


Biogen & Xbrane Join Forces to Advance Xcimzane

This article was originally published on TipRanks.com Multinational biotechnology company Biogen Inc.

Biogen Delivers Mixed Q4 Results; Shares Hit All-Time Low

This article was originally published on TipRanks.com Biopharmaceutical company Biogen Inc.

Biogen Hits All Time Low After CMS Draft Limits Usage of Aduhelm

This article was originally published on TipRanks.com Shares of biopharmaceutical company Biogen, Inc.

Samsung Group in Talks to Take Over Biogen – Report

This article was originally published on TipRanks.com Biogen Inc.

Biogen & Eisai Receive FDA Fast Track Designation for Lecanemab

This article was originally published on TipRanks.com Biogen Inc.

Biogen Slashes Prices of Aduhelm by 50%; Street Says Buy

This article was originally published on TipRanks.com Biogen Inc.

Biogen Receives Negative Opinion on Aducanumab’s MAA

This article was originally published on TipRanks.com Biogen Inc.

Biogen & TheraPanacea Join Forces to Advance Digital Health Solutions

This article was originally published on TipRanks.com Multinational biotechnology company Biogen, Inc.

Biogen Gets EU Marketing Approval for MS Treatment Vumerity

The European Commission (EC) has given its green light to Biogen, Inc. (BIIB) to market its multiple sclerosis (MS) treatment Vumerity (diroximel fumarate) …

Biogen Gains 3.2% on Positive ADUHELM Phase 3 Data

Shares of Biogen Inc. (BIIB) gained 3.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts